Ascendis Pharma Opens Compassionate Use Program for TransCon™ PTH (palopegteriparatide) in Germany
Ascendis Pharma Opens Compassionate Use Program for TransCon™ PTH (palopegteriparatide) in Germany
MDxHealth Announces its Extraordinary General Shareholders’ Meeting
MDxHealth Announces its Extraordinary General Shareholders’ Meeting
Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma
All 7 out of 7 eligible patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or…
All 7 out of 7 eligible patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or…
ERAS-007 100 mg BID-QW + encorafenib + cetuximab (EC) in EC-naïve patients with BRAFm CRC…
ERAS-007 100 mg BID-QW + encorafenib + cetuximab (EC) in EC-naïve patients with BRAFm CRC…
BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company…
BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company…
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
Aggregate Gross Proceeds of $143.7 Million from Public Offering and Private Placement THE WOODLANDS, Texas,…
Experienced Nuclear Leader Jon Ball Named to Lead Next Phase of Global Deployment CRANBERRY TOWNSHIP,…
Vancouver, British Columbia–(Newsfile Corp. – June 5, 2023) – Hillcrest Energy Technologies (CSE: HEAT) (OTCQB:…
Toronto, Ontario and New York, New York–(Newsfile Corp. – June 5, 2023) – Micromem Technologies…
LeanTaaS’ unique combination of award-winning AI, the largest hospital operations dataset, and 100+ team of…
–(BUSINESS WIRE)–$KEYS #ATE–Keysight Technologies, Inc. (NYSE: KEYS): What: The automotive industry is embracing new technologies…
Banking Tech USA Awards Honored Wealth Plan for Expanding Access to Wealth Management NEW YORK–(BUSINESS…
GERMANTOWN, Wis.–(BUSINESS WIRE)–VBA, a leading technology company for healthcare payers, announced an innovation in its…
FLORHAM PARK, N.J., June 05, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
FLORHAM PARK, N.J., June 05, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
As previously reported, avasopasem reduced cisplatin-related chronic kidney disease by 50% compared to placebo at…
As previously reported, avasopasem reduced cisplatin-related chronic kidney disease by 50% compared to placebo at…